Compounds > aluminum sulfate
Page last updated: 2024-08-22

aluminum sulfate and g(m3) ganglioside

aluminum sulfate has been researched along with g(m3) ganglioside in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alfonso, S; Areces, F; Cepeda, M; Chong, E; Crombet, T; de la Torre, AV; Flores, YI; García, E; González, Z; Guerra, PP; Hernández, AM; Hernández, M; Macías, AE; Mazorra, Z; Mendoza, IC; Ortiz, RA; Pérez, K; Pérez, R; Santiesteban, ER; Toledo, D; Valdés-Zayas, A; Vázquez, AM; Viada, CE1
Hernández, AM; Vázquez, AM1

Reviews

1 review(s) available for aluminum sulfate and g(m3) ganglioside

ArticleYear
Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer.
    Expert review of vaccines, 2015, Volume: 14, Issue:1

    Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cancer Vaccines; Carcinoma, Non-Small-Cell Lung; G(M3) Ganglioside; Humans; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome

2015

Trials

1 trial(s) available for aluminum sulfate and g(m3) ganglioside

ArticleYear
A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Jul-15, Volume: 20, Issue:14

    Topics: Adjuvants, Immunologic; Alum Compounds; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cancer Vaccines; Carcinoma, Non-Small-Cell Lung; Double-Blind Method; Female; G(M3) Ganglioside; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Staging; Placebos; Proportional Hazards Models; Treatment Outcome

2014